Search by Drug Name or NDC
NDC 50090-2031-01 Glyburide and Metformin Hydrochloride 2.5; 500 mg/1; mg/1 Details
Glyburide and Metformin Hydrochloride 2.5; 500 mg/1; mg/1
Glyburide and Metformin Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is GLYBURIDE; METFORMIN HYDROCHLORIDE.
MedlinePlus Drug Summary
The combination of glyburide and metformin is used to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood) in people whose diabetes cannot be controlled by diet and exercise alone. Glyburide belongs to a class of drugs called sulfonylureas, and metformin is in a class of drugs called biguanides. Glyburide lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently. This medication will only help lower blood sugar in people whose bodies produce insulin naturally. Metformin helps your body control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver. It also helps your body use its own insulin more effectively. Glyburide and metformin are not used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may occur if high blood sugar is not treated).
Related Packages: 50090-2031-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Glyburide and Metformin
Product Information
NDC | 50090-2031 |
---|---|
Product ID | 50090-2031_9aa83bd4-6703-4194-be6a-8956e30e5ad0 |
Associated GPIs | 27997002400320 |
GCN Sequence Number | 022735 |
GCN Sequence Number Description | glyburide/metformin HCl TABLET 2.5-500 MG ORAL |
HIC3 | C4S |
HIC3 Description | ANTIHYPERGLYCEMIC,INSULIN-RELEASE STIM.-BIGUANIDE |
GCN | 92889 |
HICL Sequence Number | 009690 |
HICL Sequence Number Description | GLYBURIDE/METFORMIN HCL |
Brand/Generic | Generic |
Proprietary Name | Glyburide and Metformin Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Glyburide and Metformin Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 2.5; 500 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | GLYBURIDE; METFORMIN HYDROCHLORIDE |
Labeler Name | A-S Medication Solutions |
Pharmaceutical Class | Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA077870 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50090-2031-01 (50090203101)
NDC Package Code | 50090-2031-1 |
---|---|
Billing NDC | 50090203101 |
Package | 30 TABLET, FILM COATED in 1 BOTTLE (50090-2031-1) |
Marketing Start Date | 2015-09-24 |
NDC Exclude Flag | N |
Pricing Information | N/A |